Research finds link between unhealthy eating and chronic pain severity, calls for comprehensive dietary support

BioArctic develops disease-modifying therapies for neurodegenerative ailments. Credit: Chinnapong / Shutterstock.com. The Japanese Patent Office (JPO) has granted a new drug substance patent for Swedish biopharma company

A randomized trial testing whether first-line disease-modifying therapy (DMT) for multiple sclerosis could be discontinued in people with stable disease was terminated early after several